215 related articles for article (PubMed ID: 27425382)
41. Cabergoline treatment in cats with diabetes mellitus and hypersomatotropism.
Miceli DD; García JD; Pompili GA; Rey Amunategui JP; Ferraris S; Pignataro OP; Guitelman M
J Feline Med Surg; 2022 Dec; 24(12):1238-1244. PubMed ID: 35133181
[TBL] [Abstract][Full Text] [Related]
42. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus.
Villa-Manzano AI; Gamez-Nava JI; Salazar-Paramo M; Valera-Gonzalez IC; Garcia-Gonzalez A; Garcia-Gonzalez G; Morales-Romero J; Lopez-Olivo A; Galvan-Ramirez LM; Ruiz-Ruvalcaba R; Cardona-Muñoz EG; Gonzalez-Lopez L
Rheumatol Int; 2006 Jun; 26(8):712-6. PubMed ID: 16231121
[TBL] [Abstract][Full Text] [Related]
43. Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome.
Piovesan A; Terzolo M; Reimondo G; Pia A; Codegone A; Osella G; Boccuzzi A; Paccotti P; Angeli A
Horm Metab Res; 1994 May; 26(5):234-7. PubMed ID: 8076906
[TBL] [Abstract][Full Text] [Related]
44. Influence of demographic factors and sport type on growth hormone-responsive markers in elite athletes.
Nelson AE; Howe CJ; Nguyen TV; Leung KC; Trout GJ; Seibel MJ; Baxter RC; Handelsman DJ; Kazlauskas R; Ho KK
J Clin Endocrinol Metab; 2006 Nov; 91(11):4424-32. PubMed ID: 16912136
[TBL] [Abstract][Full Text] [Related]
45. Measurement of amino terminal propeptide of type III procollagen (PIIINP) employing the ADVIA Centaur platform. Validation, reference interval and comparison to UniQ RIA.
Knudsen CS; Heickendorff L; Nexo E
Clin Chem Lab Med; 2014 Feb; 52(2):237-41. PubMed ID: 24114914
[TBL] [Abstract][Full Text] [Related]
46. Procollagen type III amino terminal propeptide concentrations in dogs with idiopathic pulmonary fibrosis compared with chronic bronchitis and eosinophilic bronchopneumopathy.
Heikkilä HP; Krafft E; Jespers P; McEntee K; Rajamäki MM; Clercx C
Vet J; 2013 Apr; 196(1):52-6. PubMed ID: 22909956
[TBL] [Abstract][Full Text] [Related]
47. Effect of insulin on serum amino-terminal propeptide of type III procollagen in non-insulin-dependent diabetes mellitus.
Sotaniemi EA; Stenbäck FG; Risteli L; Vuori JA; Rautio A; Huupponen R; Risteli J
Diabetes Res Clin Pract; 1992 Sep; 17(3):209-15. PubMed ID: 1425160
[TBL] [Abstract][Full Text] [Related]
48. Aminoterminal propeptide of type III procollagen in serum during wound healing in human beings.
Haukipuro K; Risteli L; Kairaluoma MI; Risteli J
Surgery; 1990 Apr; 107(4):381-8. PubMed ID: 2321135
[TBL] [Abstract][Full Text] [Related]
49. [Effect of GH/IGF-I deficiency on bone and collagen turnover in children and adults with GH deficiency].
Sartorio A; Conti A; Monzani M; Ferrero S; Biella O; Casati G; Faglia G
Minerva Endocrinol; 1995 Jun; 20(2):135-40. PubMed ID: 8531895
[TBL] [Abstract][Full Text] [Related]
50. Circulating matrix metalloproteinases and procollagen propeptides in inguinal hernia.
Li J; Zhang X; Sun Q; Li W; Yu A; Fu H; Chen K
Hernia; 2018 Jun; 22(3):541-547. PubMed ID: 29484522
[TBL] [Abstract][Full Text] [Related]
51. Renal shear wave elastography and urinary procollagen type III amino-terminal propeptide (uPIIINP) in feline chronic kidney disease.
Thanaboonnipat C; Sutayatram S; Buranakarl C; Choisunirachon N
BMC Vet Res; 2019 Feb; 15(1):54. PubMed ID: 30744640
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of insulin-like growth factor-1, total thyroxine, feline pancreas-specific lipase and urinary corticoid-to-creatinine ratio in cats with diabetes mellitus in Switzerland and the Netherlands.
Schaefer S; Kooistra HS; Riond B; Suchodolski JS; Steiner JM; Prins M; Zini E; Reusch CE
J Feline Med Surg; 2017 Aug; 19(8):888-896. PubMed ID: 27578200
[TBL] [Abstract][Full Text] [Related]
53. Procollagen type III aminoterminal propeptide as biomarker of host response in severe sepsis.
Zakynthinos S; Papanikolaou S; Mentzelopoulos S; Konstandelou E; Psachoulia C; Mavrommatis A
J Crit Care; 2013 Oct; 28(5):577-85. PubMed ID: 23683562
[TBL] [Abstract][Full Text] [Related]
54. Amino-terminal propeptide of type III procollagen: a new prognosis indicator in human ovarian cancer.
Kauppila A; Puistola U; Risteli J; Risteli L
Cancer Res; 1989 Apr; 49(7):1885-9. PubMed ID: 2924328
[TBL] [Abstract][Full Text] [Related]
55. Markers of type I and type III collagen synthesis in serum as indicators of tissue growth during pregnancy.
Puistola U; Risteli L; Kauppila A; Knip M; Risteli J
J Clin Endocrinol Metab; 1993 Jul; 77(1):178-82. PubMed ID: 8325940
[TBL] [Abstract][Full Text] [Related]
56. The N-terminal propeptide of type III procollagen in patients with acute coronary syndrome: a link between left ventricular end-diastolic pressure and cardiovascular events.
Lee CH; Lee WC; Chang SH; Wen MS; Hung KC
PLoS One; 2015; 10(1):e114097. PubMed ID: 25559610
[TBL] [Abstract][Full Text] [Related]
57. Hypersomatotropism, acromegaly, and hyperadrenocorticism and feline diabetes mellitus.
Niessen SJ; Church DB; Forcada Y
Vet Clin North Am Small Anim Pract; 2013 Mar; 43(2):319-50. PubMed ID: 23522175
[TBL] [Abstract][Full Text] [Related]
58. Hepatic and renal extraction of circulating type III procollagen amino-terminal propeptide and hyaluronan in pig.
Bentsen KD; Henriksen JH; Boesby S; Hørslev-Petersen K; Lorenzen I
J Hepatol; 1989 Sep; 9(2):177-83. PubMed ID: 2809157
[TBL] [Abstract][Full Text] [Related]
59. Serum type III procollagen peptide in patients with Pneumocystis carinii infection. The Copenhagen-Amsterdam PCP-Prednisolone Study Group.
Bentsen KD; Nielsen TL; Eaftinck Schattenkerk JK; Jensen BN; Lundgren JD
Am Rev Respir Dis; 1993 Dec; 148(6 Pt 1):1558-62. PubMed ID: 8256900
[TBL] [Abstract][Full Text] [Related]
60. Changes of procollagen type III N-terminal propeptide (PIIINP) concentrations during healing of mandible fractures treated with biodegradable and titanium fixations.
Borys J; Antonowicz B; Grabowska SZ
Adv Med Sci; 2013; 58(2):434-41. PubMed ID: 24421219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
